| Literature DB >> 34322364 |
Prashant Nasa1, Ravi Jain2, Deven Juneja3.
Abstract
The Delphi technique is a systematic process of forecasting using the collective opinion of panel members. The structured method of developing consensus among panel members using Delphi methodology has gained acceptance in diverse fields of medicine. The Delphi methods assumed a pivotal role in the last few decades to develop best practice guidance using collective intelligence where research is limited, ethically/logistically difficult or evidence is conflicting. However, the attempts to assess the quality standard of Delphi studies have reported significant variance, and details of the process followed are usually unclear. We recommend systematic quality tools for evaluation of Delphi methodology; identification of problem area of research, selection of panel, anonymity of panelists, controlled feedback, iterative Delphi rounds, consensus criteria, analysis of consensus, closing criteria, and stability of the results. Based on these nine qualitative evaluation points, we assessed the quality of Delphi studies in the medical field related to coronavirus disease 2019. There was inconsistency in reporting vital elements of Delphi methods such as identification of panel members, defining consensus, closing criteria for rounds, and presenting the results. We propose our evaluation points for researchers, medical journal editorial boards, and reviewers to evaluate the quality of the Delphi methods in healthcare research. ©The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.Entities:
Keywords: Consensus; Coronavirus disease 2019; Delphi studies; Delphi technique; Expert panel; Quality tools for methodology; Research methods; SARS-CoV-2
Year: 2021 PMID: 34322364 PMCID: PMC8299905 DOI: 10.5662/wjm.v11.i4.116
Source DB: PubMed Journal: World J Methodol ISSN: 2222-0682
Figure 1Stepwise quality assessment of Delphi studies.
Figure 2Stability assessment for Delphi rounds.
Evaluation of Delphi studies on coronavirus disease 2019 that were published in 2020 on nine qualitative evaluation points
|
|
|
|
|
|
|
| 1 | Vitacca | Rehabilitation | Italy, Europe | Consensus on pulmonary rehabilitation in patients with COVID-19 after discharge from acute care. | Recommendations from experts’ panel. |
| 2 | Mikuls | Rheumatology | USA, North America | Guidance to rheumatology providers on the management of adult rheumatic diseases during COVID-19 pandemic. | 77 initial guidance statements converted to 25 final guidance statements. |
| 3 | Greenhalgh | Primary health | UK, Europe | To develop early warning score for patients with suspected COVID-19 who need escalation to next level of care. | Development of software for early warning score in COVID-19 patients. |
| 4 | Lamb | Respiratory medicine and critical care medicine | USA, NA | Guidance to physicians on the preparation, timing, and technique of tracheostomy in COVID-19 patients. | Eight recommendations. |
| 5 | Welsh Surgical Research Initiative (WSRI) Collaborative[ | General surgery | Global | Identify the needs of the global OR workforce during COVID-19. | Statements, predominantly standardization of OR pathways, OR staffing, and preoperative screening or diagnosis. |
| 6 | Eibensteiner | Nephrology | Europe | To gather expert knowledge and experience to guide the care of children with chronic kidney disease during the COVID-19 pandemic. | Qualitative expert statements and answers. |
| 7 | Bhandari | Gastroenterology | Global | Guidance on how to resume endoscopy services during COVID-19. | Best practice recommendations to aid the safe resumption of endoscopy services globally in the era of COVID-19. |
| 8 | Guckenberger | Radiotherapy | NA and Europe | To develop practice recommendations pertaining to safe radiotherapy for lung cancer patients during COVID-19 pandemic. | Consensus recommendations in common clinical scenarios of radiotherapy for lung cancer. |
| 9 | Aj | General surgery | NA, Europe and Australia | Validation of international COVID-19 surgical guidance during COVID-19 pandemic. | Area of consensus and contentious areas from previous guidelines. |
| 10 | Gelfand | Dermatology | NA | Guidance on the management of psoriatic disease during the COVID-19 pandemic. | 22 guidance statements. |
| 11 | Allan | Surgery | Global | Guidance on surgery and OR practices during COVID-19 pandemic. | Development of research priorities in discipline of surgery related to COVID-19. |
| 12 | Shanbehzadeh | Medical informatics and public health | Iran, Middle east | Development of minimum data set for COVID-19 surveillance system. | Conceptual COVID-19 surveillance model. |
| 13 | Bergman | Long-term nursing care | NA | Consensus guidance statements focusing on essential family caregivers and visitors in nursing homes during COVID-19 pandemic. | Recommendations for visitors in long term nursing homes. |
| 14 | Daigle | Ophthalmology | Canada | Risk stratifying for oculofacial plastic and orbital surgeries in context of transmission of SARS-CoV-2. | Risk based algorithm for oculoplastic surgeries and recommendations for appropriate PPE. |
| 15 | Sorbello | Anaesthesia | Europe | Review of available evidence and scientific publications about barrier-enclosure systems for airway management in suspected/confirmed COVID-19 patients. | Recommendation on enclosure barrier systems. |
| 16 | Jheon | Cardiovascular and thoracic surgery | Asia | Thoracic cancer surgery during COVID-19 pandemic. | Recommendations on timing, approach, type of surgery, and postoperative requirements. |
| 17 | Olmos-Gómez | Behavioural sciences | Spain, Europe | To know the impact of learning environments and psychological factors. | Future research priorities. |
| 18 | Sawhney | Gastroenterology | Global | Study to emphasize patient-important outcomes while considering procedural timing. | Recommendations on procedural timing for common indications for advanced endoscopy during COVID-19. |
| 19 | Sciubba | Neurosurgery | USA | Study to device scoring system to help with triaging surgical patients during the COVID-19 pandemic. | Scoring system to triage spinal surgery cases during COVID-19 pandemic. |
| 20 | Errett | Environmental health science | USA | Study to develop an Environmental Health Sciences COVID-19 research agenda. | To validate, find limitations, and identify future research priorities. |
| 21 | Arezzo | Minimal access surgery | Global | To study and provide recommendations for recovery plan in minimally invasive surgery amid COVID-19 pandemic. | Framework for resumption of surgery with focus on minimally invasive surgeries following COVID-19 pandemic. |
| 22 | Dashash | Healthcare education | Syria | To identify essential competencies required for approaching patients with COVID-19. | Core competency points for health care professionals to prepare them for COVID-19 pandemic. |
| 23 | Ramalho | Psychiatry | Global | To create a practical and clinically useful protocol for mental health care to be applied in the pandemic. | Consensus protocol for use of telemedicine in psychiatry consults during COVID-19 pandemic. |
| 24 | Saldarriaga Rivera | Rheumatology | Columbia, SA | To produce recommendations for patients with rheumatological diseases receiving immunomodulatory and immunosuppressive therapies. | Recommendations for pharmacological management of patients with rheumatic diseases during COVID-19 pandemic. |
| 25 | Tchouaket Nguemeleu | Public health | Canada, NA | Study for development and validation of a time and motion guide to assess the costs of prevention and control interventions for nosocomial infections. | Development and validation of a new instrument for systematic assessment of costs relating to the human and material resources used in nosocomial infection prevention and control. |
| 26 | Santana | Nursing | Brazil, SA | To develop an adaptable acceptable nursing protocol during the pandemic. | Protocol for nurse managers to cope with pandemic. |
| 27 | Tang | Oncology | China | To develop a risk model based on the experience of recently resumed activities in many cancer hospitals in China to reduce nosocomial transmission of SARS-CoV-2. | Risk model development on the basis of experience from recently resumed cancer hospital. |
| 28 | Jiménez-Rodríguez | Public health | Spain | Develop recommendations for telemedicine in video consultations during COVID-19. | Consensus recommendations for healthcare professionals for proper management of video consultation. |
| 29 | Reina Ortiz | Public health | Ecuador | Development of bio-safety measures to reduce cross-transmission of SARS-CoV-2. | Biosafety-at-home flyer for high-risk group and health care workers to reduce the risk of cross-transmission. |
| 30 | Douillet | Internal medicine | France and Belgium | Identify reliable criteria for hospitalization or outpatient management in mild cases of COVID-19. | Development of toolkit “HOME-CoV rule”, a decision-making support mechanism for clinicians to target patients with suspected or confirmed COVID-19 requiring hospitalization. |
| 31 | Richez | Rheumatology | France | Management of anti-inflammatory agents and disease-modifying-anti-rheumatic-drugs for rheumatological patients during COVID-19. | Recommendations to rheumatologists on management. |
| 32 | Yalçınkaya | Physiotherapy and rehabilitation medicine | Turkey | Recommendations for the management of spasticity in Cerebral palsy children during COVID-19 pandemic. | Consensus recommendations for spasticity management in cerebral palsy children. |
| 33 | Tanasijevic | Haemato-oncology | USA | To identify minimum hemoglobin for safe transfusion in myelodysplastic syndrome during COVID-19 pandemic. | Recommendations for lowest value of hemoglobin for which transfusions can safely forgo. |
| 34 | Alarcón | Dentistry | Latin America | Education and practice in implant Dentistry during COVID-19 pandemic. | Consensus recommendations. |
COVID-19: Coronavirus disease 2019; SARS-CoV-2: Severe acute respiratory syndrome coronavirus 2; OR: Operating room.
Basic information of the Delphi studies included for evaluation
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 | Vitacca | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | No | 2 | 20 |
| 2 | Mikuls | Yes | Yes | Not clear | Yes | Yes | Yes | Yes | Yes | No | 2 | 14 |
| 3 | Greenhalgh | Yes | Not clear | Yes | Yes | Yes | Not clear | Yes | Yes | No | 4 | 72 |
| 4 | Lamb | Yes | Yes | No | No | No | Yes | Yes | Yes | No | 1 | 13 |
| 5 | Welsh Surgical Research Initiative (WSRI) Collaborative[ | Yes | No | Yes | No | No | Yes | Yes | Yes | No | 1 | 339 |
| 6 | Eibensteiner | Yes | Yes | Not clear | Yes | Yes | No | No | No | No | 4 | 13 |
|
| Bhandari | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | No | 2 | 34 |
| 8 | Guckenberger | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | No | 3 | 32 |
| 9 | Aj | Yes | No | Yes | Yes | No | Yes | Yes | Yes | No | 1 | 339 |
| 10 | Gelfand | Yes | No | Yes | Yes | Yes | Yes | Yes | Yes | No | 2 | 18 |
| 11 | Allan | No | No | Yes | No | Yes | Yes | Yes | No | No | 3 | 213 |
| 12 | Shanbehzadeh | Yes | Yes | No | No | Yes | Yes | Yes | Yes | No | 2 | 40 |
| 13 | Bergman | Yes | Yes | No | Yes | Yes | Yes | Yes | Yes | No | 2 | 21 |
| 14 | Daigle | Yes | Yes | Not clear | Yes | Yes | Yes | Yes | Yes | No | 2 | 18 |
| 15 | Sorbello | Yes | Not clear | Not clear | Not clear | Not clear | Not clear | Not clear | Not clear | Not clear | - | 0 |
| 16 | Jheon | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | No | 2 | 26 |
| 17 | Olmos-Gómez | Yes | Yes | Not clear | Not clear | Yes | Yes | Yes | Yes | Yes | 3 | 441 |
| 18 | Sawhney | Not clear | Not clear | Not clear | Yes | Yes | Yes | Yes | No | Not clear | 3 | 14 |
| 19 | Sciubba | Not clear | Not clear | No | Not clear | Yes | No | Yes | No | Not clear | 3 | 16 |
| 20 | Errett | Not clear | Not clear | Yes | Not clear | Yes | Yes | Yes | Yes | No | 3 | 28 |
| 21 | Arezzo | Yes | Not clear | Yes | Yes | No | Yes | Yes | Yes | No | 2 | 55 |
| 22 | Dashash | Yes | Not clear | Not clear | Yes | No | Yes | Yes | No | No | 3 | 20 |
| 23 | Ramalho | Yes | Not clear | Not clear | Yes | Yes | Yes | Yes | Not clear | No | 2 | 16 |
| 24 | Saldarriaga Rivera | Yes | No | Not clear | Yes | Yes | Yes | Yes | Not clear | No | 3 | 11 |
| 25 | Tchouaket Nguemeleu | Yes | Yes | No | Yes | Yes | Yes | Yes | Yes | Yes | 2 | 18 |
| 26 | Santana | No | Not clear | No | Yes | Yes | Yes | Yes | No | Not clear | 4 | 6 |
| 27 | Tang | Yes | Yes | Not clear | No | Not clear | No | No | No | No | 1 | 83 |
| 28 | Jiménez-Rodríguez | No | Yes | Not clear | Yes | Yes | Yes | Yes | Yes | No | 3 | 16 |
| 29 | Reina Ortiz | No | Yes | Not clear | Yes | Yes | No | No | Not clear | No | 2 | 12 |
| 30 | Douillet | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Not clear | 4 | 51 |
| 31 | Richez | Yes | Yes | No | Yes | No | No | No | Not clear | No | 2 | 10 |
| 32 | Yılmaz Yalçınkaya | Yes | Yes | Not clear | No | No | Yes | Yes | No | No | 1 | 60 |
| 33 | Tanasijevic | Yes | Yes | No | Yes | Yes | Yes | Yes | Yes | No | 3 | 13 |
| 34 | Alarcón | Yes | Yes | No | Yes | Yes | Yes | Yes | Yes | No | 3 | 197 |